Início › Síndromes Mielodisplásicas › Califórnia

Ensaios clínicos de Síndromes Mielodisplásicas em Califórnia

41 estudos para Síndromes Mielodisplásicas estão buscando participantes em locais em Califórnia.

Cidades em Califórnia

Texto oficial do estudo (Inglês)

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06577441

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

City of Hope, Duarte
UC Davis, Sacramento
Stanford Health Care, Stanford

RecrutandoFase 1

Idades de 12 a 78 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT03802695

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
e mais 21

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

City of Hope - Duarte, Duarte
City of Hope - Lennar, Irvine
UCLA, Los Angeles
e mais 1

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT05320198

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

City of Hope - Comprehensive Cancer Center (CCC), Duarte
Providence Medical Group, Santa Rosa
Cancer & Blood Research Center, Whittier

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT07422480

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

City of Hope National Medical Center, Duarte

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT06846606

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Kaiser Permanente Downey Medical Center, Downey
Loma Linda University Medical Center, Loma Linda
Miller Children's and Women's Hospital Long Beach, Long Beach
e mais 8

RecrutandoFase 1/2

Até 22 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04726241

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

City of Hope, Duarte
Los Angeles Cancer Network, Glendale
UC San Diego Moores Cancer Center, La Jolla

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06499285

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

Lucille Packard Children's Hospital of Stanford University, Palo Alto

RecrutandoFase 1

18 Months – 39 Years · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT07573111

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

City of Hope National Medical Center, Duarte

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT04419649

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

City of Hope Medical Center, Duarte

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07582172

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT06656494

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

Stanford University, Palo Alto

RecrutandoFase 1

Idades de 18 a 80 · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT07302776

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

University of California, Los Angeles, Los Angeles
University of California, Irvine, Orange
Stanford Cancer Institute, Palo Alto

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT05308264

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

City of Hope Medical Center, Duarte

RecrutandoFase 1

Idades de 18 a 70 · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT06287944

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

City of Hope Medical Center, Duarte

RecrutandoFase 1Voluntários saudáveis bem-vindos

Idades de 18 a 75 · Todos os sexos · Atualizado em 28 de jul. de 2026 · NCT07020533

Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

City of Hope Medical Center, Duarte

RecrutandoFase 1

Idades de 18 a 75 · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT06498973

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

UCLA Department of Medicine, Los Angeles

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT07216443

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

City of Hope Medical Center, Duarte

RecrutandoFase 1

Idades de 18 a 75 · Todos os sexos · Atualizado em 1 de jul. de 2026 · NCT06996119

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

City of Hope Medical Center, Duarte

RecrutandoFase 2

Idades de 18 a 80 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT06815003

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Stanford University, Palo Alto

RecrutandoFase 1

Idades de 18 a 70 · Todos os sexos · Atualizado em 23 de jun. de 2026 · NCT06551584

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

City of Hope, Duarte

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 17 de jun. de 2026 · NCT03113643

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

GSK Investigational Site, Duarte
GSK Investigational Site, Irvine

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de jun. de 2026 · NCT06847867

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Beckman Research Institute of City of Hope, Duarte
VA Medical Center, Fresno, Fresno
Santa Clara Valley Medical Center, Fruitdale
e mais 5

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 30 de abr. de 2026 · NCT05297734

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Keck School of Medicine of USC, Los Angeles
UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de abr. de 2026 · NCT04256317

Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

City of Hope Medical Center, Duarte

RecrutandoFase 1Voluntários saudáveis bem-vindos

Idades 60 e acima · Todos os sexos · Atualizado em 29 de abr. de 2026 · NCT06195891

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

City of Hope Medical Center, Duarte

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 13 de abr. de 2026 · NCT06146257

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 27 de mar. de 2026 · NCT06063486

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Hoag Family Cancer Center, Newport Beach
Stanford University, Palo Alto

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 24 de mar. de 2026 · NCT04988555

Venetoclax Basket Trial for High Risk Hematologic Malignancies

University of California San Francisco-Benioff Children's Hospital, San Francisco

RecrutandoFase 1

Idades de 1 a 40 · Todos os sexos · Atualizado em 12 de mar. de 2026 · NCT05292664

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

City of Hope Medical Center, Duarte

RecrutandoFase 2Voluntários saudáveis bem-vindos

Idades de 18 a 75 · Todos os sexos · Atualizado em 10 de mar. de 2026 · NCT06059391

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

City of Hope Medical Center, Duarte

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 5 de mar. de 2026 · NCT06543381

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

UCLA, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 16 de jan. de 2026 · NCT05143996

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

University of California Davis Health (UC Davis Health), Sacramento

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 5 de jan. de 2026 · NCT05184842

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

City of Hope Medical Center, Duarte

RecrutandoFase 2

Idades de 10 a 30 · Todos os sexos · Atualizado em 4 de dez. de 2025 · NCT05194397

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

City of Hope Medical Center, Duarte

RecrutandoFase 2

Idades de 2 a 22 · Todos os sexos · Atualizado em 31 de out. de 2025 · NCT06128070

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duarte
Massive Bio SYNERGY-AI site, Irvine
Massive Bio SYNERGY-AI site, La Jolla
e mais 3

RecrutandoEstudo observacional

Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

City of Hope Medical Center, Duarte
University of California Los Angeles, Los Angeles
Stanford Cancer Center, Palo Alto

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2025 · NCT06501196

Study of REM-422 in Patients With AML or Higher Risk MDS

City of Hope, Duarte

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 23 de abr. de 2025 · NCT06297941

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

City of Hope, Duarte

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 15 de abr. de 2025 · NCT06462365

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.